2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Hepatitis B
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Hepatocellular
1
Interventions
entecavir
10
Lamivudine
5
Tenofovir
4
lenvatinib
2
Sorafenib
2
Radiofrequency Ablation
2
Hepatitis B Vaccines
2
tenofovir alafenamide
1
polysaccharide MGN3
1
peginterferon alfa-2b
1
peginterferon alfa-2a
1
navitoclax
1
menatetrenone
1
lens intermediate filament proteins
1
human papillomavirus vaccine, L1 type 16, 18
1
hepatitis B hyperimmune globulin
1
bicyclol
1
adefovir dipivoxil
1
adefovir
1
Urinalysis
1
Ultrasonography
1
Tumor Necrosis Factor-alpha
1
Tetanus Toxoid
1
Telbivudine
1
Tablets
1
Standard of Care
1
Rapid Diagnostic Tests
1
Raltegravir Potassium
1
Radiomics
1
Practice Guidelines as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hepatitis B
×
Telbivudine
×
Clear all
NCT01102335
2010-04-13
TACEHBV
Fudan University
Phase 4
Unknown
80 enrolled